VANGUARD GROUP INC 13D and 13G filings for Ironwood Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-31 11:44 am Sale | 2024-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | VANGUARD GROUP INC | 19,538,555 12.200% | -2,499,542 (-11.34%) | Filing |
| 2024-11-12 3:47 pm Unchanged | 2024-09-30 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | VANGUARD GROUP INC | 22,038,097 13.790% | 0 (Unchanged) | Filing |
| 2024-11-04 11:46 am Purchase | 2024-09-30 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | VANGUARD GROUP INC | 22,038,097 13.790% | 6,004,552 (+37.45%) | Filing |
| 2024-01-10 10:16 am Purchase | 2023-12-29 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | VANGUARD GROUP INC | 16,033,545 10.270% | 1,300,976 (+8.83%) | Filing |
| 2023-02-09 11:22 am Purchase | 2022-12-30 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | VANGUARD GROUP INC | 14,732,569 9.600% | 1,244,807 (+9.23%) | Filing |
| 2022-02-10 08:22 am Sale | 2021-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | VANGUARD GROUP INC | 13,487,762 8.240% | -2,404,585 (-15.13%) | Filing |
| 2021-02-10 11:10 am Sale | 2020-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | VANGUARD GROUP INC | 15,892,347 9.930% | -746,594 (-4.49%) | Filing |